CirculationGenetic & Genomic MedicinePeer-reviewed journal article
A polygenic predictor of baseline QTc is associated with sotalol-induced QT prolongation
Megan Cummins LancasteriD, Giovanni DavogusttoiD, Edi PriftiiD, Claire PerretiD, Christian Funck‐BrentanoiD, Dan M. RodeniD, Joe‐Elie SalemiD
Abstract
BackgroundDrug-induced QT interval prolongation raises the risk of fatal arrhythmia and is a central issue in safety pharmacology. Yet individual QT drug response is highly variable, and risk stratification remains a challenge. We hypothesized that genetic factors underlying the baseline QT influence this variation in QT drug response. MethodsA cohort of 990 healthy subjects was prospectively challenged with a single 80 mg oral sotalol dose. Exclusion criteria included abnormal ECG, cardiac disease, and QT-prolonging drug use. ECGs were obtained at baseline and 3 hours post-dose. QT response was defined as absolute change in Fridericia heart-rate corrected QT ({Delta}QTc). Plasma sotalol was measured 3 hours post-dose. Subjects were genotyped on the MEGA array. Principal component analysis of genotypes was used to define genetic ancestry. A polygenic risk score (PRS) for the baseline QTc comprised of 465,399 common variants was calculated from assayed and imputed genotypes. The difference in PRS between subjects with high QT response ({Delta}QTc[≥]60 ms) and those with {Delta}QTc<60ms was assessed by Mann Whitney test. A multivariable regression model was used to assess the association between PRS and {Delta}QTc after covariate adjustment. Results: Of the 990 subjects, 978 (99%) passed genomic quality control and were included in analysis. 62% were female (n=607), with median age 23 (interquartile range (IQR) 21-33). The median {Delta}QTc 3 hours post-sotalol was 21 ms (IQR 12-30). Ten subjects (1%) had {Delta}QTc[≥]60 ms, and their PRS was significantly higher compared to those with {Delta}QTc<60 ms (P=0.0082). In the regression model, PRS was positively associated with {Delta}QTc (P=0.0002). ConclusionCommon genetic variants associated with the baseline QT also capture part of the repolarization response to sotalol. This adds to the emerging concept that the genetic architecture of a trait can predict drug response.
- organism: human
- assay: electronic health records
- research focus: differential expression
- approach: statistical model
- Citations
- 5
- FWCI
- 1.50
- Field percentile
- top 14%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Polygenic Risk Score predicts QTc-prolongation and Short-Term Mortality in Patients using QT-prolonging Psychoactive Medications
Mays Altaraihi·medRxiv·Jul 24, 2024
- The effect of sex and underlying disease on the genetic association of QT interval and sudden cardiac death
Rebecca N. Mitchell, Foram N. Ashar, … Dan E. Arking·Journal of the American Heart AssociationPeer-reviewed·Nov 21, 2019
- Multicenter Analysis of Dosing Protocols for Sotalol Initiation
M. Biswas, A. E. Levy, … M. A. Rosenberg·bioRxiv·Jan 29, 2019
- Genetic analyses of the QT interval and its components in over 250K individuals identifies new loci and pathways affecting ventricular depolarization and repolarization
William John Young, Najim Lahrouchi, … Antônio Luiz Pinho Ribeiro·Nature CommunicationsPeer-reviewed·Sep 1, 2022
- Monogenic and Polygenic Contributions to QTc Prolongation in the Population
Victor D. Nauffal, Valerie N. Morrill, … for the TOPMed Investigators·CirculationPeer-reviewed·Apr 7, 2022
- Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes
K. H. Jaeger, S. Wall, A. Tveito·PLOS Computational BiologyPeer-reviewed·Feb 16, 2021